NCT06365229

Brief Summary

A prospective study aimed to compare the efficacy and safety of Unilateral biportal endoscopic (UBE) technique and uniportal endoscopic (UE) technique for treating patients with lumbar spinal stenosis (LSS).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2023

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

April 7, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

April 15, 2024

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

July 2, 2025

Status Verified

April 1, 2025

Enrollment Period

2 years

First QC Date

April 7, 2024

Last Update Submit

June 30, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Oswestry Disability Index (ODI)

    0-100%, the higher the score, the more severe the lumbar spine dysfunction

    From enrollment to the end of follow-up at 1 year

Secondary Outcomes (24)

  • Magnetic resonance imaging (MRI)

    From enrollment to the follow-up at 2 weeks

  • Computed tomography (CT) scans

    From enrollment to the end of follow-up at 2 weeks

  • Creatine kinase (CK)

    From enrollment to the end of follow-up at 2 weeks

  • Erythrocyte sedimentation rate (ESR)

    From enrollment to the follow-up at 2 weeks

  • Surgical complication

    From enrollment to the end of follow-up at 1 year

  • +19 more secondary outcomes

Study Arms (2)

UBE Group

Patients with LSS undergoing UBE

UE Group

Patients with LSS undergoing UE

Eligibility Criteria

Age50 Years - 80 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with LSS undergoing UBE or UE decompression performed by two experienced spine surgeons at the same hospital will be recruited for the study.

You may qualify if:

  • Age range: 50-80 years
  • Diagnosed with LSS of 1-2 response levels
  • The predominant manifestation is neurogenic intermittent claudication, and conservative treatment has been ineffective for at least 3 months
  • Degenerative lumbar spondylolisthesis of less than I degree or without spine instability
  • Patients agree to participate in the study and are willing to complete the follow-up

You may not qualify if:

  • Isthmic lumbar spondylolisthesis or degenerative lumbar spondylolisthesis of greater than I degree
  • Instability at the response level
  • Prior surgical history at the response level
  • Scoliosis with Cobb angle \>20 degrees
  • Other conditions affecting the lumbar spine (infection, tumor, fracture, neurological diseases, and others)
  • Patients with medical disorders who are unable to tolerate surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Beijing Friendship Hospital

Beijing, Beijing Municipality, 100050, China

Location

Related Publications (1)

  • Tan H, Liu Y, Li G, Yu L, Yang Y, Lo Y, Bin Z, Li X. Percutaneous unilateral biportal endoscopy versus uniportal endoscopy for lumbar spinal stenosis: a single-centre, prospective, non-randomised cohort trial protocol. BMJ Open. 2025 Jul 25;15(7):e087863. doi: 10.1136/bmjopen-2024-087863.

MeSH Terms

Conditions

Spinal Stenosis

Condition Hierarchy (Ancestors)

Spinal DiseasesBone DiseasesMusculoskeletal Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Year
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 7, 2024

First Posted

April 15, 2024

Study Start

January 1, 2023

Primary Completion

December 31, 2024

Study Completion

December 31, 2024

Last Updated

July 2, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations